Safran to Sell Morpho Detection
April 22, 2016
Safran announced it has reached an agreement to sell Morpho Detection LLC, a U.S.-based subsidiary of Safran, and other detection-related activities to Smiths Group plc for an enterprise value of $710 million.
Headquartered in Newark, Calif., Morpho Detection provides solutions for detecting and identifying chemical, biological, radiological, nuclear and explosive threats as well as other illicit items to improve security at airports, borders and sensitive sites and events. Morpho Detection is part of Safran’s Morpho business within its Security segment, and recorded revenue of $320 million in 2015.
Morpho Detection will become part of Smiths Group plc’s detection segment, which designs and manufactures sensors that detect and identify explosives, weapons, chemical agents and other contraband.
“Morpho Detection is in a number of detection segments and global markets and very well positioned to benefit from attractive trends in its end markets,” said Philippe Petitcolin, CEO of Safran. “We believe it will be a very valuable addition to Smiths Group’s portfolio. This transaction is in line with our announced strategy to focus our development on the aerospace and defense markets.”
Andrew Reynolds Smith, chief executive of Smiths Group plc., said, “The threat environment for people and critical infrastructure around the world is constantly evolving and becoming more complex and sophisticated. The response, to keep people safe and the world running, demands cutting-edge technology and cost-efficient solutions.
Smith added, “Morpho Detection is a high quality business with a strong management team, and I am convinced that this combination provides a compelling competitive platform for product, service and technology leadership. The acquisition is consistent with our approach to increasingly focus investment in highly attractive technology-led markets, and will create significant value for shareholders and position us for long-term growth.”
The transaction will generate a capital gain before tax at the current €/$ exchange rate.
The transaction is subject to regulatory approvals and customary closing conditions, and is expected to be completed early in 2017.